What dose of bacopa monnieri do studies and the Egyptian monograph give?
| Trial | Dose and schedule | People | Length |
|---|---|---|---|
| Calabrese 2008 | 300 mg/day extract tablet or placebo, orally1 | 54 randomized, aged 65 or older; 24 completers per group | 12 weeks after a 6-week placebo run-in |
| Peth-Nui 2012 | 300 or 600 mg extract or placebo, once daily2 | 60 healthy elderly, 20 per group | 12 weeks |
| Morgan 2010 | 300 mg/day BacoMind or placebo3 | 98 healthy people over 55 commenced, 81 completed | 12 weeks |
| Sathyanarayanan 2013 | 450 mg single daily dose or placebo6 | 72 healthy adults aged 35-60 | 12 weeks |
| Kumar 2016 | 150 mg of extract or placebo twice daily (300 mg/day)7 | Sixty medical students | six weeks |
| Lopresti 2025 | 300 mg daily Bacumen (n = 50) or placebo (n = 51)4 | 101 aged 40-70 with self-reported memory and attention problems | 12 weeks |
| Downey 2013 (acute crossover) | Single dose of placebo, 320 mg or 640 mg8 | Twenty-four healthy volunteers | One dose of each, crossover |
Doses in named trials
The table is set at the top of the page
Daily doses in the adult trials in the table ran from 300 mg to 600 mg, and one single-dose crossover gave 320 mg or 640 mg; 300 mg a day for 12 weeks was the most common, and the open-label Dave 2014 study in thirty-one children gave 225 mg/d.1273489 Extract strength differs by brand, so mg figures are not comparable across products.
What the monograph says and what is sold
The Egyptian Drug Authority monograph, based on long-standing traditional use, gives oral use: 1–10 gm, daily of the powdered drug for adults and elderly, and, for adolescents, adults and elderly, 200 - 400 mg daily in divided doses of a dry ethanolic extract standardized to 20% bacosides A and B, or 300 mg daily in divided doses of one standardized to 40- 55% bacosides A and B.5 A DailyMed search returned only homeopathic or multi-ingredient labels, and none a single-ingredient bacopa label with a dose.
Products, duration, timing and storage
Nootropics Depot lists a Bacognize capsule of 300mg standardized to a minimum of 12% bacosides by HPLC, and LifeLab lists a Bacopa Monnieri Extract Powder 50%.1011
The monograph gives at least 6 weeks of use to see beneficial effects, and the Calabrese 2008 paper notes that the Stough 2001 trial, in 46 healthy volunteers aged 18–60 given 300 mg of B. monnieri extract daily, showed effects at 12 weeks but not at 5 weeks.51 Trials in these sources ran from six weeks (Kumar 2016) to 14 weeks (Kean 2022), registry entry NCT02931747 lists 16 weeks, and the open-label Dave 2014 study in children ran 6 mo; a 2021 review reports that Goswami et al. studied the effect over 6 months of a daily dose of 600 mg B. monnieri in 39 patients with Alzheimer’s disease, in an open label, non-randomized, non-controlled study.71213914 None of the sources searched gives an on and off cycle, and none of the trials in them tested stopping and restarting. None of the trial papers or the Egyptian monograph searched states whether bacopa is given with food. No regulator, label or trial text in the sources searched says which liquid or how much to mix bacopa powder with. Neither the Egyptian monograph nor the trial papers searched give storage conditions, before or after opening or mixing.
Frequently asked questions
What is the usual bacopa monnieri dosage per day in human trials?
A systematic review cited in the Peth-Nui 2012 trial reports that doses of 300–450 mg/day can enhance memory recall.2
What dose was used in children with ADHD?
An open-label study by Dave and colleagues (2014) of thirty-one children aged 6-12 with ADHD gave 225 mg/d of BacoMind extract for 6 mo.9 The Kean 2022 placebo-controlled trial of CDRI 08 in boys aged 6 to 14 with inattention and hyperactivity ran 14 weeks, with placebo run-in and run-out phases, recruited one-hundred and twelve and analysed 93 datasets, and noted no significant behavioural differences between treatment groups; its dose is not given in the text searched.12 For children 6 - 12 in general, not ADHD alone, the Egyptian Drug Authority monograph lists 100 - 200 mg daily in divided doses of its 20% bacosides extract.5
Is there a registered clinical trial of bacopa, and what dose does it use?
Registry entry NCT02931747 (Khon Kaen University, 75 enrolled, healthy students aged 15-18) lists arms of placebo, 300 mg/day and 600 mg/day once daily for 16 weeks.13 Entry NCT02462642 (Unilever R&D, healthy Indian adults) lists 225 mg of Brahmi extract per capsule, two such capsules per day, to be taken by the subjects for 12 weeks, in 36 subjects against placebo in 36 subjects.15 Entry NCT04927338, a phase II study in Gulf War Illness that plans to randomize 170 participants, lists 12 weeks of 300 mg/day BacoMind extract versus placebo.16 A ClinicalTrials.gov search for bacopa returned more registered studies than these three, which are the ones fetched.
References
- PubMed Central. Effects of a Standardized Bacopa monnieri Extract on Cognitive Performance, Anxiety, and Depression in the Elderly: A Randomized, Double-Blind, Placebo-Controlled Trial. 2008. pmc.ncbi.nlm.nih.gov
- PubMed Central. Effects of 12-Week Bacopa monnieri Consumption on Attention, Cognitive Processing, Working Memory, and Functions of Both Cholinergic and Monoaminergic Systems in Healthy Elderly Volunteers. 2012. pmc.ncbi.nlm.nih.gov
- PubMed. Does Bacopa monnieri improve memory performance in older persons? Results of a randomized, placebo-controlled, double-blind trial. 2010. pubmed.ncbi.nlm.nih.gov
- PubMed. The Effects of a Bacopa monnieri Extract (Bacumen®) on Cognition, Stress, and Fatigue in Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Trial. 2025. pubmed.ncbi.nlm.nih.gov
- Egyptian Drug Authority. Herbal Monograph on Wild Medicinal Plants in Egypt. 2024. edaegypt.gov.eg
- PubMed. Brahmi for the better? New findings challenging cognition and anti-anxiety effects of Brahmi (Bacopa monniera) in healthy adults. 2013. pubmed.ncbi.nlm.nih.gov
- PubMed Central. Efficacy of Standardized Extract of Bacopa monnieri (Bacognize®) on Cognitive Functions of Medical Students: A Six-Week, Randomized Placebo-Controlled Trial. 2016. pmc.ncbi.nlm.nih.gov
- PubMed. An acute, double-blind, placebo-controlled crossover study of 320 mg and 640 mg doses of a special extract of Bacopa monnieri (CDRI 08) on sustained cognitive performance. 2013. pubmed.ncbi.nlm.nih.gov
- PubMed. An open-label study to elucidate the effects of standardized Bacopa monnieri extract in the management of symptoms of attention-deficit hyperactivity disorder in children. 2014. pubmed.ncbi.nlm.nih.gov
- Nootropics Depot. Bacognize® Bacopa monnieri Capsules. nootropicsdepot.com
- LifeLab. Bacopa Monnieri Extract Powder 50%. lifelabsupplements.com
- PubMed. Effects of Bacopa monnieri (CDRI 08®) in a population of males exhibiting inattention and hyperactivity aged 6 to 14 years: A randomized, double-blind, placebo-controlled trial. 2022. pubmed.ncbi.nlm.nih.gov
- ClinicalTrials.gov. NCT02931747: Effect of Bacopa Monnieri on Working Memory and Cognitive Processing in Student. 2017. clinicaltrials.gov
- PubMed Central. The effectiveness of Bacopa monnieri (Linn.) Wettst . as a nootropic, neuroprotective, or antidepressant supplement: analysis of the available clinical data. 2021. pmc.ncbi.nlm.nih.gov
- ClinicalTrials.gov. NCT02462642: Effect of Bacopa Monniera Extract on Cognition and Anxiety and Exploration of PK Properties. 2010. clinicaltrials.gov
- ClinicalTrials.gov. NCT04927338: Study of Bacopa in Gulf War Illness Patients. 2022. clinicaltrials.gov